C4 Therapeutics Inc
NASDAQ:CCCC

Watchlist Manager
C4 Therapeutics Inc Logo
C4 Therapeutics Inc
NASDAQ:CCCC
Watchlist
Price: 2.58 USD -0.39% Market Closed
Market Cap: 250m USD

Wall Street
Price Targets

CCCC Price Targets Summary
C4 Therapeutics Inc

Wall Street analysts forecast CCCC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CCCC is 12.09 USD with a low forecast of 6.06 USD and a high forecast of 30.45 USD.

Lowest
Price Target
6.06 USD
135% Upside
Average
Price Target
12.09 USD
369% Upside
Highest
Price Target
30.45 USD
1 080% Upside
C4 Therapeutics Inc Competitors:
Price Targets
688278
Xiamen Amoytop Biotech Co Ltd
20% Upside
RXRX
Recursion Pharmaceuticals Inc
35% Upside
IMTX
Immatics NV
85% Upside
MGX
Metagenomi Inc
423% Upside
RPTX
Repare Therapeutics Inc
42% Upside
ENTA
Enanta Pharmaceuticals Inc
35% Upside
301047
Sino Biological Inc
17% Upside
GBIO
Generation Bio Co
462% Upside

Revenue
Forecast

Revenue Estimate
C4 Therapeutics Inc

For the last 5 years the compound annual growth rate for C4 Therapeutics Inc's revenue is 11%. The projected CAGR for the next 3 years is -15%.

11%
Past Growth
-15%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
C4 Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
C4 Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-50%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CCCC's stock price target?
Price Target
12.09 USD

According to Wall Street analysts, the average 1-year price target for CCCC is 12.09 USD with a low forecast of 6.06 USD and a high forecast of 30.45 USD.

What is C4 Therapeutics Inc's Revenue forecast?
Projected CAGR
-15%

For the last 5 years the compound annual growth rate for C4 Therapeutics Inc's revenue is 11%. The projected CAGR for the next 3 years is -15%.

Back to Top